IBDEI0DP ; ; 03-MAY-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,34368,1,3,0)
;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,In Remission
;;^UTILITY(U,$J,358.3,34368,1,4,0)
;;=4^C91.11
;;^UTILITY(U,$J,358.3,34368,2)
;;=^5001766
;;^UTILITY(U,$J,358.3,34369,0)
;;=C91.10^^105^1433^53
;;^UTILITY(U,$J,358.3,34369,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34369,1,3,0)
;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,Not in Remission
;;^UTILITY(U,$J,358.3,34369,1,4,0)
;;=4^C91.10
;;^UTILITY(U,$J,358.3,34369,2)
;;=^5001765
;;^UTILITY(U,$J,358.3,34370,0)
;;=C92.11^^105^1433^54
;;^UTILITY(U,$J,358.3,34370,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34370,1,3,0)
;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,In Remission
;;^UTILITY(U,$J,358.3,34370,1,4,0)
;;=4^C92.11
;;^UTILITY(U,$J,358.3,34370,2)
;;=^5001793
;;^UTILITY(U,$J,358.3,34371,0)
;;=C92.10^^105^1433^55
;;^UTILITY(U,$J,358.3,34371,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34371,1,3,0)
;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,Not in Remission
;;^UTILITY(U,$J,358.3,34371,1,4,0)
;;=4^C92.10
;;^UTILITY(U,$J,358.3,34371,2)
;;=^5001792
;;^UTILITY(U,$J,358.3,34372,0)
;;=D47.1^^105^1433^56
;;^UTILITY(U,$J,358.3,34372,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34372,1,3,0)
;;=3^Chronic Myeloproliferative Disease
;;^UTILITY(U,$J,358.3,34372,1,4,0)
;;=4^D47.1
;;^UTILITY(U,$J,358.3,34372,2)
;;=^5002256
;;^UTILITY(U,$J,358.3,34373,0)
;;=C82.69^^105^1433^57
;;^UTILITY(U,$J,358.3,34373,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34373,1,3,0)
;;=3^Cutaneous Follicle Center Lymphoma,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,34373,1,4,0)
;;=4^C82.69
;;^UTILITY(U,$J,358.3,34373,2)
;;=^5001530
;;^UTILITY(U,$J,358.3,34374,0)
;;=C82.60^^105^1433^58
;;^UTILITY(U,$J,358.3,34374,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34374,1,3,0)
;;=3^Cutaneous Follicle Center Lymphoma,Unspec Site
;;^UTILITY(U,$J,358.3,34374,1,4,0)
;;=4^C82.60
;;^UTILITY(U,$J,358.3,34374,2)
;;=^5001521
;;^UTILITY(U,$J,358.3,34375,0)
;;=D56.2^^105^1433^59
;;^UTILITY(U,$J,358.3,34375,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34375,1,3,0)
;;=3^Delta-Beta Thalassemia
;;^UTILITY(U,$J,358.3,34375,1,4,0)
;;=4^D56.2
;;^UTILITY(U,$J,358.3,34375,2)
;;=^340496
;;^UTILITY(U,$J,358.3,34376,0)
;;=D75.9^^105^1433^60
;;^UTILITY(U,$J,358.3,34376,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34376,1,3,0)
;;=3^Disease of Blood/Blood-Forming Organs,Unspec
;;^UTILITY(U,$J,358.3,34376,1,4,0)
;;=4^D75.9
;;^UTILITY(U,$J,358.3,34376,2)
;;=^5002393
;;^UTILITY(U,$J,358.3,34377,0)
;;=D59.0^^105^1433^63
;;^UTILITY(U,$J,358.3,34377,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34377,1,3,0)
;;=3^Drug-Induced Autoimmune Hemolytic Anemia
;;^UTILITY(U,$J,358.3,34377,1,4,0)
;;=4^D59.0
;;^UTILITY(U,$J,358.3,34377,2)
;;=^5002323
;;^UTILITY(U,$J,358.3,34378,0)
;;=D59.2^^105^1433^64
;;^UTILITY(U,$J,358.3,34378,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34378,1,3,0)
;;=3^Drug-Induced Nonautoimmune Hemolytic Anemia
;;^UTILITY(U,$J,358.3,34378,1,4,0)
;;=4^D59.2
;;^UTILITY(U,$J,358.3,34378,2)
;;=^5002325
;;^UTILITY(U,$J,358.3,34379,0)
;;=R59.9^^105^1433^67
;;^UTILITY(U,$J,358.3,34379,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34379,1,3,0)
;;=3^Enlarged Lymph Nodes,Unspec
;;^UTILITY(U,$J,358.3,34379,1,4,0)
;;=4^R59.9
;;^UTILITY(U,$J,358.3,34379,2)
;;=^5019531
;;^UTILITY(U,$J,358.3,34380,0)
;;=D47.3^^105^1433^68
;;^UTILITY(U,$J,358.3,34380,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34380,1,3,0)
;;=3^Essential Thrombocythemia
;;^UTILITY(U,$J,358.3,34380,1,4,0)
;;=4^D47.3
;;^UTILITY(U,$J,358.3,34380,2)
;;=^5002258
;;^UTILITY(U,$J,358.3,34381,0)
;;=C82.09^^105^1433^69
;;^UTILITY(U,$J,358.3,34381,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34381,1,3,0)
;;=3^Follicular Lymphoma Grade I,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,34381,1,4,0)
;;=4^C82.09
;;^UTILITY(U,$J,358.3,34381,2)
;;=^5001470
;;^UTILITY(U,$J,358.3,34382,0)
;;=C82.00^^105^1433^70
;;^UTILITY(U,$J,358.3,34382,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34382,1,3,0)
;;=3^Follicular Lymphoma Grade I,Unspec Site
;;^UTILITY(U,$J,358.3,34382,1,4,0)
;;=4^C82.00
;;^UTILITY(U,$J,358.3,34382,2)
;;=^5001461
;;^UTILITY(U,$J,358.3,34383,0)
;;=C82.19^^105^1433^71
;;^UTILITY(U,$J,358.3,34383,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34383,1,3,0)
;;=3^Follicular Lymphoma Grade II,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,34383,1,4,0)
;;=4^C82.19
;;^UTILITY(U,$J,358.3,34383,2)
;;=^5001480
;;^UTILITY(U,$J,358.3,34384,0)
;;=C82.10^^105^1433^72
;;^UTILITY(U,$J,358.3,34384,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34384,1,3,0)
;;=3^Follicular Lymphoma Grade II,Unspec Site
;;^UTILITY(U,$J,358.3,34384,1,4,0)
;;=4^C82.10
;;^UTILITY(U,$J,358.3,34384,2)
;;=^5001471
;;^UTILITY(U,$J,358.3,34385,0)
;;=C82.29^^105^1433^73
;;^UTILITY(U,$J,358.3,34385,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34385,1,3,0)
;;=3^Follicular Lymphoma Grade III,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,34385,1,4,0)
;;=4^C82.29
;;^UTILITY(U,$J,358.3,34385,2)
;;=^5001490
;;^UTILITY(U,$J,358.3,34386,0)
;;=C82.20^^105^1433^74
;;^UTILITY(U,$J,358.3,34386,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34386,1,3,0)
;;=3^Follicular Lymphoma Grade III,Unspec Site
;;^UTILITY(U,$J,358.3,34386,1,4,0)
;;=4^C82.20
;;^UTILITY(U,$J,358.3,34386,2)
;;=^5001481
;;^UTILITY(U,$J,358.3,34387,0)
;;=C82.39^^105^1433^75
;;^UTILITY(U,$J,358.3,34387,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34387,1,3,0)
;;=3^Follicular Lymphoma Grade IIIa,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,34387,1,4,0)
;;=4^C82.39
;;^UTILITY(U,$J,358.3,34387,2)
;;=^5001500
;;^UTILITY(U,$J,358.3,34388,0)
;;=C82.30^^105^1433^76
;;^UTILITY(U,$J,358.3,34388,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34388,1,3,0)
;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
;;^UTILITY(U,$J,358.3,34388,1,4,0)
;;=4^C82.30
;;^UTILITY(U,$J,358.3,34388,2)
;;=^5001491
;;^UTILITY(U,$J,358.3,34389,0)
;;=C82.49^^105^1433^77
;;^UTILITY(U,$J,358.3,34389,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34389,1,3,0)
;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,34389,1,4,0)
;;=4^C82.49
;;^UTILITY(U,$J,358.3,34389,2)
;;=^5001510
;;^UTILITY(U,$J,358.3,34390,0)
;;=C82.40^^105^1433^78
;;^UTILITY(U,$J,358.3,34390,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34390,1,3,0)
;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
;;^UTILITY(U,$J,358.3,34390,1,4,0)
;;=4^C82.40
;;^UTILITY(U,$J,358.3,34390,2)
;;=^5001501
;;^UTILITY(U,$J,358.3,34391,0)
;;=C82.99^^105^1433^79
;;^UTILITY(U,$J,358.3,34391,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34391,1,3,0)
;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,34391,1,4,0)
;;=4^C82.99
;;^UTILITY(U,$J,358.3,34391,2)
;;=^5001550
;;^UTILITY(U,$J,358.3,34392,0)
;;=C82.90^^105^1433^80
;;^UTILITY(U,$J,358.3,34392,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34392,1,3,0)
;;=3^Follicular Lymphoma Unspec,Unspec Site
;;^UTILITY(U,$J,358.3,34392,1,4,0)
;;=4^C82.90
;;^UTILITY(U,$J,358.3,34392,2)
;;=^5001541
;;^UTILITY(U,$J,358.3,34393,0)
;;=R59.1^^105^1433^65
;;^UTILITY(U,$J,358.3,34393,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34393,1,3,0)
;;=3^Enlarged Lymph Nodes,Generalized
;;^UTILITY(U,$J,358.3,34393,1,4,0)
;;=4^R59.1
;;^UTILITY(U,$J,358.3,34393,2)
;;=^5019530
;;^UTILITY(U,$J,358.3,34394,0)
;;=C91.40^^105^1433^84
;;^UTILITY(U,$J,358.3,34394,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34394,1,3,0)
;;=3^Hairy Cell Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,34394,1,4,0)
;;=4^C91.40
;;^UTILITY(U,$J,358.3,34394,2)
;;=^5001771
;;^UTILITY(U,$J,358.3,34395,0)
;;=C91.42^^105^1433^82
;;^UTILITY(U,$J,358.3,34395,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34395,1,3,0)
;;=3^Hairy Cell Leukemia,In Relapse
;;^UTILITY(U,$J,358.3,34395,1,4,0)
;;=4^C91.42
;;^UTILITY(U,$J,358.3,34395,2)
;;=^5001773
;;^UTILITY(U,$J,358.3,34396,0)
;;=C91.41^^105^1433^83
;;^UTILITY(U,$J,358.3,34396,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34396,1,3,0)
;;=3^Hairy Cell Leukemia,In Remission
;;^UTILITY(U,$J,358.3,34396,1,4,0)
;;=4^C91.41
;;^UTILITY(U,$J,358.3,34396,2)
;;=^5001772
;;^UTILITY(U,$J,358.3,34397,0)
;;=D57.01^^105^1433^85
;;^UTILITY(U,$J,358.3,34397,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34397,1,3,0)
;;=3^Hb-SS Disease w/ Acute Chest Syndrome
;;^UTILITY(U,$J,358.3,34397,1,4,0)
;;=4^D57.01
;;^UTILITY(U,$J,358.3,34397,2)
;;=^5002307
;;^UTILITY(U,$J,358.3,34398,0)
;;=D57.00^^105^1433^86
;;^UTILITY(U,$J,358.3,34398,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34398,1,3,0)
;;=3^Hb-SS Disease w/ Crisis,Unspec
;;^UTILITY(U,$J,358.3,34398,1,4,0)
;;=4^D57.00
;;^UTILITY(U,$J,358.3,34398,2)
;;=^5002306
;;^UTILITY(U,$J,358.3,34399,0)
;;=D57.02^^105^1433^87
;;^UTILITY(U,$J,358.3,34399,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34399,1,3,0)
;;=3^Hb-SS Disease w/ Splenic Sequestration
;;^UTILITY(U,$J,358.3,34399,1,4,0)
;;=4^D57.02
;;^UTILITY(U,$J,358.3,34399,2)
;;=^5002308
;;^UTILITY(U,$J,358.3,34400,0)
;;=D68.32^^105^1433^89
;;^UTILITY(U,$J,358.3,34400,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34400,1,3,0)
;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
;;^UTILITY(U,$J,358.3,34400,1,4,0)
;;=4^D68.32
;;^UTILITY(U,$J,358.3,34400,2)
;;=^5002357
;;^UTILITY(U,$J,358.3,34401,0)
;;=C22.2^^105^1433^90
;;^UTILITY(U,$J,358.3,34401,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34401,1,3,0)
;;=3^Hepatoblastoma
;;^UTILITY(U,$J,358.3,34401,1,4,0)
;;=4^C22.2
;;^UTILITY(U,$J,358.3,34401,2)
;;=^5000935
;;^UTILITY(U,$J,358.3,34402,0)
;;=D58.9^^105^1433^92
;;^UTILITY(U,$J,358.3,34402,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34402,1,3,0)
;;=3^Hereditary Hemolytic Anemia,Unspec
;;^UTILITY(U,$J,358.3,34402,1,4,0)
;;=4^D58.9
;;^UTILITY(U,$J,358.3,34402,2)
;;=^5002322
;;^UTILITY(U,$J,358.3,34403,0)
;;=C81.99^^105^1433^93
;;^UTILITY(U,$J,358.3,34403,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34403,1,3,0)
;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,34403,1,4,0)
;;=4^C81.99
;;^UTILITY(U,$J,358.3,34403,2)
;;=^5001460
;;^UTILITY(U,$J,358.3,34404,0)
;;=C81.90^^105^1433^94
;;^UTILITY(U,$J,358.3,34404,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34404,1,3,0)
;;=3^Hodgkin Lymphoma,Unspec Site
;;^UTILITY(U,$J,358.3,34404,1,4,0)
;;=4^C81.90
;;^UTILITY(U,$J,358.3,34404,2)
;;=^5001451
;;^UTILITY(U,$J,358.3,34405,0)
;;=D89.2^^105^1433^95
;;^UTILITY(U,$J,358.3,34405,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34405,1,3,0)
;;=3^Hypergammaglobulenemia,Unspec
;;^UTILITY(U,$J,358.3,34405,1,4,0)
;;=4^D89.2
;;^UTILITY(U,$J,358.3,34405,2)
;;=^5002455
;;^UTILITY(U,$J,358.3,34406,0)
;;=D05.12^^105^1433^98
;;^UTILITY(U,$J,358.3,34406,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34406,1,3,0)
;;=3^Intraductal Carcinoma in Situ,Left Breast
;;^UTILITY(U,$J,358.3,34406,1,4,0)
;;=4^D05.12
;;^UTILITY(U,$J,358.3,34406,2)
;;=^5001931
;;^UTILITY(U,$J,358.3,34407,0)
;;=D05.11^^105^1433^99
;;^UTILITY(U,$J,358.3,34407,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34407,1,3,0)
;;=3^Intraductal Carcinoma in Situ,Right Breast
;;^UTILITY(U,$J,358.3,34407,1,4,0)
;;=4^D05.11
;;^UTILITY(U,$J,358.3,34407,2)
;;=^5001930
;;^UTILITY(U,$J,358.3,34408,0)
;;=D05.10^^105^1433^100
;;^UTILITY(U,$J,358.3,34408,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34408,1,3,0)
;;=3^Intraductal Carcinoma in Situ,Unspec Breast
;;^UTILITY(U,$J,358.3,34408,1,4,0)
;;=4^D05.10
;;^UTILITY(U,$J,358.3,34408,2)
;;=^5001929
;;^UTILITY(U,$J,358.3,34409,0)
;;=D50.0^^105^1433^101
;;^UTILITY(U,$J,358.3,34409,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34409,1,3,0)
;;=3^Iron Deficiency Anemia Secondary to Blood Loss
;;^UTILITY(U,$J,358.3,34409,1,4,0)
;;=4^D50.0
;;^UTILITY(U,$J,358.3,34409,2)
;;=^267971
;;^UTILITY(U,$J,358.3,34410,0)
;;=D50.9^^105^1433^102
;;^UTILITY(U,$J,358.3,34410,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34410,1,3,0)
;;=3^Iron Deficiency Anemia,Unspec
;;^UTILITY(U,$J,358.3,34410,1,4,0)
;;=4^D50.9
;;^UTILITY(U,$J,358.3,34410,2)
;;=^5002283
;;^UTILITY(U,$J,358.3,34411,0)
;;=C46.9^^105^1433^103
;;^UTILITY(U,$J,358.3,34411,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34411,1,3,0)
;;=3^Kaposi's Sarcoma,Unspec
;;^UTILITY(U,$J,358.3,34411,1,4,0)
;;=4^C46.9
;;^UTILITY(U,$J,358.3,34411,2)
;;=^5001108
;;^UTILITY(U,$J,358.3,34412,0)
;;=C22.0^^105^1433^104
;;^UTILITY(U,$J,358.3,34412,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34412,1,3,0)
;;=3^Liver Cell Carcinoma
;;^UTILITY(U,$J,358.3,34412,1,4,0)
;;=4^C22.0
;;^UTILITY(U,$J,358.3,34412,2)
;;=^5000933
;;^UTILITY(U,$J,358.3,34413,0)
;;=D05.02^^105^1433^105
;;^UTILITY(U,$J,358.3,34413,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34413,1,3,0)
;;=3^Lobular Carcinoma in Situ,Left Breast
;;^UTILITY(U,$J,358.3,34413,1,4,0)
;;=4^D05.02
;;^UTILITY(U,$J,358.3,34413,2)
;;=^5001928
;;^UTILITY(U,$J,358.3,34414,0)
;;=D05.01^^105^1433^106
;;^UTILITY(U,$J,358.3,34414,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34414,1,3,0)
;;=3^Lobular Carcinoma in Situ,Right Breast
;;^UTILITY(U,$J,358.3,34414,1,4,0)
;;=4^D05.01
;;^UTILITY(U,$J,358.3,34414,2)
;;=^5001927
;;^UTILITY(U,$J,358.3,34415,0)
;;=D05.00^^105^1433^107
;;^UTILITY(U,$J,358.3,34415,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34415,1,3,0)
;;=3^Lobular Carcinoma in Situ,Unspec Breast
;;^UTILITY(U,$J,358.3,34415,1,4,0)
;;=4^D05.00
;;^UTILITY(U,$J,358.3,34415,2)
;;=^5001926
;;^UTILITY(U,$J,358.3,34416,0)
;;=R59.0^^105^1433^66
;;^UTILITY(U,$J,358.3,34416,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34416,1,3,0)
;;=3^Enlarged Lymph Nodes,Localized
;;^UTILITY(U,$J,358.3,34416,1,4,0)
;;=4^R59.0
;;^UTILITY(U,$J,358.3,34416,2)
;;=^5019529
;;^UTILITY(U,$J,358.3,34417,0)
;;=C83.59^^105^1433^108
;;^UTILITY(U,$J,358.3,34417,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34417,1,3,0)
;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,34417,1,4,0)
;;=4^C83.59
;;^UTILITY(U,$J,358.3,34417,2)
;;=^5001590
;;^UTILITY(U,$J,358.3,34418,0)
;;=C83.50^^105^1433^109
;;^UTILITY(U,$J,358.3,34418,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34418,1,3,0)
;;=3^Lymphoblastic Lymphoma,Unspec Site
;;^UTILITY(U,$J,358.3,34418,1,4,0)
;;=4^C83.50
;;^UTILITY(U,$J,358.3,34418,2)
;;=^5001581
;;^UTILITY(U,$J,358.3,34419,0)
;;=C43.9^^105^1433^112
;;^UTILITY(U,$J,358.3,34419,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34419,1,3,0)
;;=3^Malig Melanoma of Skin,Unspec Site
;;^UTILITY(U,$J,358.3,34419,1,4,0)
;;=4^C43.9
;;^UTILITY(U,$J,358.3,34419,2)
;;=^5001015
;;^UTILITY(U,$J,358.3,34420,0)
;;=C31.9^^105^1433^113
;;^UTILITY(U,$J,358.3,34420,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34420,1,3,0)
;;=3^Malig Neop Accessory Sinus,Unspec
;;^UTILITY(U,$J,358.3,34420,1,4,0)
;;=4^C31.9
;;^UTILITY(U,$J,358.3,34420,2)
;;=^5000953
;;^UTILITY(U,$J,358.3,34421,0)
;;=C24.1^^105^1433^115
;;^UTILITY(U,$J,358.3,34421,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34421,1,3,0)
;;=3^Malig Neop Ampulla of Vater
;;^UTILITY(U,$J,358.3,34421,1,4,0)
;;=4^C24.1
;;^UTILITY(U,$J,358.3,34421,2)
;;=^267100
;;^UTILITY(U,$J,358.3,34422,0)
;;=C21.0^^105^1433^116
;;^UTILITY(U,$J,358.3,34422,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34422,1,3,0)
;;=3^Malig Neop Anus,Unspec
;;^UTILITY(U,$J,358.3,34422,1,4,0)
;;=4^C21.0
;;^UTILITY(U,$J,358.3,34422,2)
;;=^5000930
;;^UTILITY(U,$J,358.3,34423,0)
;;=C67.9^^105^1433^119
;;^UTILITY(U,$J,358.3,34423,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34423,1,3,0)
;;=3^Malig Neop Bladder,Unspec
;;^UTILITY(U,$J,358.3,34423,1,4,0)
;;=4^C67.9
;;^UTILITY(U,$J,358.3,34423,2)
;;=^5001263
;;^UTILITY(U,$J,358.3,34424,0)
;;=C71.9^^105^1433^123
;;^UTILITY(U,$J,358.3,34424,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34424,1,3,0)
;;=3^Malig Neop Brain,Unspec
;;^UTILITY(U,$J,358.3,34424,1,4,0)
;;=4^C71.9
;;^UTILITY(U,$J,358.3,34424,2)
;;=^5001297
;;^UTILITY(U,$J,358.3,34425,0)
;;=C18.9^^105^1433^125
;;^UTILITY(U,$J,358.3,34425,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34425,1,3,0)
;;=3^Malig Neop Colon,Unspec
;;^UTILITY(U,$J,358.3,34425,1,4,0)
;;=4^C18.9
;;^UTILITY(U,$J,358.3,34425,2)
;;=^5000929
;;^UTILITY(U,$J,358.3,34426,0)
;;=C49.9^^105^1433^126
;;^UTILITY(U,$J,358.3,34426,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34426,1,3,0)
;;=3^Malig Neop Connective/Soft Tissue,Unspec
;;^UTILITY(U,$J,358.3,34426,1,4,0)
;;=4^C49.9
;;^UTILITY(U,$J,358.3,34426,2)
;;=^5001136
;;^UTILITY(U,$J,358.3,34427,0)
;;=C62.12^^105^1433^127
;;^UTILITY(U,$J,358.3,34427,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34427,1,3,0)
;;=3^Malig Neop Descended Left Testis
;;^UTILITY(U,$J,358.3,34427,1,4,0)
;;=4^C62.12
;;^UTILITY(U,$J,358.3,34427,2)
;;=^5001235
;;^UTILITY(U,$J,358.3,34428,0)
;;=C62.11^^105^1433^128
;;^UTILITY(U,$J,358.3,34428,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34428,1,3,0)
;;=3^Malig Neop Descended Right Testis
;;^UTILITY(U,$J,358.3,34428,1,4,0)
;;=4^C62.11
;;^UTILITY(U,$J,358.3,34428,2)
;;=^5001234
;;^UTILITY(U,$J,358.3,34429,0)
;;=C15.9^^105^1433^129
;;^UTILITY(U,$J,358.3,34429,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34429,1,3,0)
;;=3^Malig Neop Esophagus,Unspec
;;^UTILITY(U,$J,358.3,34429,1,4,0)
;;=4^C15.9
;;^UTILITY(U,$J,358.3,34429,2)
;;=^5000919
;;^UTILITY(U,$J,358.3,34430,0)
;;=C24.0^^105^1433^130
;;^UTILITY(U,$J,358.3,34430,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34430,1,3,0)
;;=3^Malig Neop Extrahepatic Bile Duct
;;^UTILITY(U,$J,358.3,34430,1,4,0)
;;=4^C24.0
;;^UTILITY(U,$J,358.3,34430,2)
;;=^5000940
;;^UTILITY(U,$J,358.3,34431,0)
;;=C23.^^105^1433^132
;;^UTILITY(U,$J,358.3,34431,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34431,1,3,0)
;;=3^Malig Neop Gallbladder
;;^UTILITY(U,$J,358.3,34431,1,4,0)
;;=4^C23.
;;^UTILITY(U,$J,358.3,34431,2)
;;=^267098
;;^UTILITY(U,$J,358.3,34432,0)
;;=C32.9^^105^1433^136
;;^UTILITY(U,$J,358.3,34432,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34432,1,3,0)
;;=3^Malig Neop Larynx,Unspec
;;^UTILITY(U,$J,358.3,34432,1,4,0)
;;=4^C32.9
;;^UTILITY(U,$J,358.3,34432,2)
;;=^5000956
;;^UTILITY(U,$J,358.3,34433,0)
;;=C64.2^^105^1433^140
;;^UTILITY(U,$J,358.3,34433,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34433,1,3,0)
;;=3^Malig Neop Left Kidney,Except Renal Pelvis
;;^UTILITY(U,$J,358.3,34433,1,4,0)
;;=4^C64.2
;;^UTILITY(U,$J,358.3,34433,2)
;;=^5001249
;;^UTILITY(U,$J,358.3,34434,0)
;;=C65.2^^105^1433^143
;;^UTILITY(U,$J,358.3,34434,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34434,1,3,0)
;;=3^Malig Neop Left Renal Pelvis
;;^UTILITY(U,$J,358.3,34434,1,4,0)
;;=4^C65.2
;;^UTILITY(U,$J,358.3,34434,2)
;;=^5001252
;;^UTILITY(U,$J,358.3,34435,0)
;;=C62.92^^105^1433^144
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0DP 19793 printed Sep 23, 2025@19:22:38 Page 2
IBDEI0DP ; ; 03-MAY-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,34368,1,3,0)
+2 ;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,In Remission
+3 ;;^UTILITY(U,$J,358.3,34368,1,4,0)
+4 ;;=4^C91.11
+5 ;;^UTILITY(U,$J,358.3,34368,2)
+6 ;;=^5001766
+7 ;;^UTILITY(U,$J,358.3,34369,0)
+8 ;;=C91.10^^105^1433^53
+9 ;;^UTILITY(U,$J,358.3,34369,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,34369,1,3,0)
+12 ;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,Not in Remission
+13 ;;^UTILITY(U,$J,358.3,34369,1,4,0)
+14 ;;=4^C91.10
+15 ;;^UTILITY(U,$J,358.3,34369,2)
+16 ;;=^5001765
+17 ;;^UTILITY(U,$J,358.3,34370,0)
+18 ;;=C92.11^^105^1433^54
+19 ;;^UTILITY(U,$J,358.3,34370,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,34370,1,3,0)
+22 ;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,In Remission
+23 ;;^UTILITY(U,$J,358.3,34370,1,4,0)
+24 ;;=4^C92.11
+25 ;;^UTILITY(U,$J,358.3,34370,2)
+26 ;;=^5001793
+27 ;;^UTILITY(U,$J,358.3,34371,0)
+28 ;;=C92.10^^105^1433^55
+29 ;;^UTILITY(U,$J,358.3,34371,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,34371,1,3,0)
+32 ;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,Not in Remission
+33 ;;^UTILITY(U,$J,358.3,34371,1,4,0)
+34 ;;=4^C92.10
+35 ;;^UTILITY(U,$J,358.3,34371,2)
+36 ;;=^5001792
+37 ;;^UTILITY(U,$J,358.3,34372,0)
+38 ;;=D47.1^^105^1433^56
+39 ;;^UTILITY(U,$J,358.3,34372,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,34372,1,3,0)
+42 ;;=3^Chronic Myeloproliferative Disease
+43 ;;^UTILITY(U,$J,358.3,34372,1,4,0)
+44 ;;=4^D47.1
+45 ;;^UTILITY(U,$J,358.3,34372,2)
+46 ;;=^5002256
+47 ;;^UTILITY(U,$J,358.3,34373,0)
+48 ;;=C82.69^^105^1433^57
+49 ;;^UTILITY(U,$J,358.3,34373,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,34373,1,3,0)
+52 ;;=3^Cutaneous Follicle Center Lymphoma,Extranodal/Solid Organ Sites
+53 ;;^UTILITY(U,$J,358.3,34373,1,4,0)
+54 ;;=4^C82.69
+55 ;;^UTILITY(U,$J,358.3,34373,2)
+56 ;;=^5001530
+57 ;;^UTILITY(U,$J,358.3,34374,0)
+58 ;;=C82.60^^105^1433^58
+59 ;;^UTILITY(U,$J,358.3,34374,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,34374,1,3,0)
+62 ;;=3^Cutaneous Follicle Center Lymphoma,Unspec Site
+63 ;;^UTILITY(U,$J,358.3,34374,1,4,0)
+64 ;;=4^C82.60
+65 ;;^UTILITY(U,$J,358.3,34374,2)
+66 ;;=^5001521
+67 ;;^UTILITY(U,$J,358.3,34375,0)
+68 ;;=D56.2^^105^1433^59
+69 ;;^UTILITY(U,$J,358.3,34375,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,34375,1,3,0)
+72 ;;=3^Delta-Beta Thalassemia
+73 ;;^UTILITY(U,$J,358.3,34375,1,4,0)
+74 ;;=4^D56.2
+75 ;;^UTILITY(U,$J,358.3,34375,2)
+76 ;;=^340496
+77 ;;^UTILITY(U,$J,358.3,34376,0)
+78 ;;=D75.9^^105^1433^60
+79 ;;^UTILITY(U,$J,358.3,34376,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,34376,1,3,0)
+82 ;;=3^Disease of Blood/Blood-Forming Organs,Unspec
+83 ;;^UTILITY(U,$J,358.3,34376,1,4,0)
+84 ;;=4^D75.9
+85 ;;^UTILITY(U,$J,358.3,34376,2)
+86 ;;=^5002393
+87 ;;^UTILITY(U,$J,358.3,34377,0)
+88 ;;=D59.0^^105^1433^63
+89 ;;^UTILITY(U,$J,358.3,34377,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,34377,1,3,0)
+92 ;;=3^Drug-Induced Autoimmune Hemolytic Anemia
+93 ;;^UTILITY(U,$J,358.3,34377,1,4,0)
+94 ;;=4^D59.0
+95 ;;^UTILITY(U,$J,358.3,34377,2)
+96 ;;=^5002323
+97 ;;^UTILITY(U,$J,358.3,34378,0)
+98 ;;=D59.2^^105^1433^64
+99 ;;^UTILITY(U,$J,358.3,34378,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,34378,1,3,0)
+102 ;;=3^Drug-Induced Nonautoimmune Hemolytic Anemia
+103 ;;^UTILITY(U,$J,358.3,34378,1,4,0)
+104 ;;=4^D59.2
+105 ;;^UTILITY(U,$J,358.3,34378,2)
+106 ;;=^5002325
+107 ;;^UTILITY(U,$J,358.3,34379,0)
+108 ;;=R59.9^^105^1433^67
+109 ;;^UTILITY(U,$J,358.3,34379,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,34379,1,3,0)
+112 ;;=3^Enlarged Lymph Nodes,Unspec
+113 ;;^UTILITY(U,$J,358.3,34379,1,4,0)
+114 ;;=4^R59.9
+115 ;;^UTILITY(U,$J,358.3,34379,2)
+116 ;;=^5019531
+117 ;;^UTILITY(U,$J,358.3,34380,0)
+118 ;;=D47.3^^105^1433^68
+119 ;;^UTILITY(U,$J,358.3,34380,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,34380,1,3,0)
+122 ;;=3^Essential Thrombocythemia
+123 ;;^UTILITY(U,$J,358.3,34380,1,4,0)
+124 ;;=4^D47.3
+125 ;;^UTILITY(U,$J,358.3,34380,2)
+126 ;;=^5002258
+127 ;;^UTILITY(U,$J,358.3,34381,0)
+128 ;;=C82.09^^105^1433^69
+129 ;;^UTILITY(U,$J,358.3,34381,1,0)
+130 ;;=^358.31IA^4^2
+131 ;;^UTILITY(U,$J,358.3,34381,1,3,0)
+132 ;;=3^Follicular Lymphoma Grade I,Extranodal/Solid Organ Sites
+133 ;;^UTILITY(U,$J,358.3,34381,1,4,0)
+134 ;;=4^C82.09
+135 ;;^UTILITY(U,$J,358.3,34381,2)
+136 ;;=^5001470
+137 ;;^UTILITY(U,$J,358.3,34382,0)
+138 ;;=C82.00^^105^1433^70
+139 ;;^UTILITY(U,$J,358.3,34382,1,0)
+140 ;;=^358.31IA^4^2
+141 ;;^UTILITY(U,$J,358.3,34382,1,3,0)
+142 ;;=3^Follicular Lymphoma Grade I,Unspec Site
+143 ;;^UTILITY(U,$J,358.3,34382,1,4,0)
+144 ;;=4^C82.00
+145 ;;^UTILITY(U,$J,358.3,34382,2)
+146 ;;=^5001461
+147 ;;^UTILITY(U,$J,358.3,34383,0)
+148 ;;=C82.19^^105^1433^71
+149 ;;^UTILITY(U,$J,358.3,34383,1,0)
+150 ;;=^358.31IA^4^2
+151 ;;^UTILITY(U,$J,358.3,34383,1,3,0)
+152 ;;=3^Follicular Lymphoma Grade II,Extranodal/Solid Organ Sites
+153 ;;^UTILITY(U,$J,358.3,34383,1,4,0)
+154 ;;=4^C82.19
+155 ;;^UTILITY(U,$J,358.3,34383,2)
+156 ;;=^5001480
+157 ;;^UTILITY(U,$J,358.3,34384,0)
+158 ;;=C82.10^^105^1433^72
+159 ;;^UTILITY(U,$J,358.3,34384,1,0)
+160 ;;=^358.31IA^4^2
+161 ;;^UTILITY(U,$J,358.3,34384,1,3,0)
+162 ;;=3^Follicular Lymphoma Grade II,Unspec Site
+163 ;;^UTILITY(U,$J,358.3,34384,1,4,0)
+164 ;;=4^C82.10
+165 ;;^UTILITY(U,$J,358.3,34384,2)
+166 ;;=^5001471
+167 ;;^UTILITY(U,$J,358.3,34385,0)
+168 ;;=C82.29^^105^1433^73
+169 ;;^UTILITY(U,$J,358.3,34385,1,0)
+170 ;;=^358.31IA^4^2
+171 ;;^UTILITY(U,$J,358.3,34385,1,3,0)
+172 ;;=3^Follicular Lymphoma Grade III,Extranodal/Solid Organ Sites
+173 ;;^UTILITY(U,$J,358.3,34385,1,4,0)
+174 ;;=4^C82.29
+175 ;;^UTILITY(U,$J,358.3,34385,2)
+176 ;;=^5001490
+177 ;;^UTILITY(U,$J,358.3,34386,0)
+178 ;;=C82.20^^105^1433^74
+179 ;;^UTILITY(U,$J,358.3,34386,1,0)
+180 ;;=^358.31IA^4^2
+181 ;;^UTILITY(U,$J,358.3,34386,1,3,0)
+182 ;;=3^Follicular Lymphoma Grade III,Unspec Site
+183 ;;^UTILITY(U,$J,358.3,34386,1,4,0)
+184 ;;=4^C82.20
+185 ;;^UTILITY(U,$J,358.3,34386,2)
+186 ;;=^5001481
+187 ;;^UTILITY(U,$J,358.3,34387,0)
+188 ;;=C82.39^^105^1433^75
+189 ;;^UTILITY(U,$J,358.3,34387,1,0)
+190 ;;=^358.31IA^4^2
+191 ;;^UTILITY(U,$J,358.3,34387,1,3,0)
+192 ;;=3^Follicular Lymphoma Grade IIIa,Extranodal/Solid Organ Sites
+193 ;;^UTILITY(U,$J,358.3,34387,1,4,0)
+194 ;;=4^C82.39
+195 ;;^UTILITY(U,$J,358.3,34387,2)
+196 ;;=^5001500
+197 ;;^UTILITY(U,$J,358.3,34388,0)
+198 ;;=C82.30^^105^1433^76
+199 ;;^UTILITY(U,$J,358.3,34388,1,0)
+200 ;;=^358.31IA^4^2
+201 ;;^UTILITY(U,$J,358.3,34388,1,3,0)
+202 ;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
+203 ;;^UTILITY(U,$J,358.3,34388,1,4,0)
+204 ;;=4^C82.30
+205 ;;^UTILITY(U,$J,358.3,34388,2)
+206 ;;=^5001491
+207 ;;^UTILITY(U,$J,358.3,34389,0)
+208 ;;=C82.49^^105^1433^77
+209 ;;^UTILITY(U,$J,358.3,34389,1,0)
+210 ;;=^358.31IA^4^2
+211 ;;^UTILITY(U,$J,358.3,34389,1,3,0)
+212 ;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
+213 ;;^UTILITY(U,$J,358.3,34389,1,4,0)
+214 ;;=4^C82.49
+215 ;;^UTILITY(U,$J,358.3,34389,2)
+216 ;;=^5001510
+217 ;;^UTILITY(U,$J,358.3,34390,0)
+218 ;;=C82.40^^105^1433^78
+219 ;;^UTILITY(U,$J,358.3,34390,1,0)
+220 ;;=^358.31IA^4^2
+221 ;;^UTILITY(U,$J,358.3,34390,1,3,0)
+222 ;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
+223 ;;^UTILITY(U,$J,358.3,34390,1,4,0)
+224 ;;=4^C82.40
+225 ;;^UTILITY(U,$J,358.3,34390,2)
+226 ;;=^5001501
+227 ;;^UTILITY(U,$J,358.3,34391,0)
+228 ;;=C82.99^^105^1433^79
+229 ;;^UTILITY(U,$J,358.3,34391,1,0)
+230 ;;=^358.31IA^4^2
+231 ;;^UTILITY(U,$J,358.3,34391,1,3,0)
+232 ;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
+233 ;;^UTILITY(U,$J,358.3,34391,1,4,0)
+234 ;;=4^C82.99
+235 ;;^UTILITY(U,$J,358.3,34391,2)
+236 ;;=^5001550
+237 ;;^UTILITY(U,$J,358.3,34392,0)
+238 ;;=C82.90^^105^1433^80
+239 ;;^UTILITY(U,$J,358.3,34392,1,0)
+240 ;;=^358.31IA^4^2
+241 ;;^UTILITY(U,$J,358.3,34392,1,3,0)
+242 ;;=3^Follicular Lymphoma Unspec,Unspec Site
+243 ;;^UTILITY(U,$J,358.3,34392,1,4,0)
+244 ;;=4^C82.90
+245 ;;^UTILITY(U,$J,358.3,34392,2)
+246 ;;=^5001541
+247 ;;^UTILITY(U,$J,358.3,34393,0)
+248 ;;=R59.1^^105^1433^65
+249 ;;^UTILITY(U,$J,358.3,34393,1,0)
+250 ;;=^358.31IA^4^2
+251 ;;^UTILITY(U,$J,358.3,34393,1,3,0)
+252 ;;=3^Enlarged Lymph Nodes,Generalized
+253 ;;^UTILITY(U,$J,358.3,34393,1,4,0)
+254 ;;=4^R59.1
+255 ;;^UTILITY(U,$J,358.3,34393,2)
+256 ;;=^5019530
+257 ;;^UTILITY(U,$J,358.3,34394,0)
+258 ;;=C91.40^^105^1433^84
+259 ;;^UTILITY(U,$J,358.3,34394,1,0)
+260 ;;=^358.31IA^4^2
+261 ;;^UTILITY(U,$J,358.3,34394,1,3,0)
+262 ;;=3^Hairy Cell Leukemia,Not in Remission
+263 ;;^UTILITY(U,$J,358.3,34394,1,4,0)
+264 ;;=4^C91.40
+265 ;;^UTILITY(U,$J,358.3,34394,2)
+266 ;;=^5001771
+267 ;;^UTILITY(U,$J,358.3,34395,0)
+268 ;;=C91.42^^105^1433^82
+269 ;;^UTILITY(U,$J,358.3,34395,1,0)
+270 ;;=^358.31IA^4^2
+271 ;;^UTILITY(U,$J,358.3,34395,1,3,0)
+272 ;;=3^Hairy Cell Leukemia,In Relapse
+273 ;;^UTILITY(U,$J,358.3,34395,1,4,0)
+274 ;;=4^C91.42
+275 ;;^UTILITY(U,$J,358.3,34395,2)
+276 ;;=^5001773
+277 ;;^UTILITY(U,$J,358.3,34396,0)
+278 ;;=C91.41^^105^1433^83
+279 ;;^UTILITY(U,$J,358.3,34396,1,0)
+280 ;;=^358.31IA^4^2
+281 ;;^UTILITY(U,$J,358.3,34396,1,3,0)
+282 ;;=3^Hairy Cell Leukemia,In Remission
+283 ;;^UTILITY(U,$J,358.3,34396,1,4,0)
+284 ;;=4^C91.41
+285 ;;^UTILITY(U,$J,358.3,34396,2)
+286 ;;=^5001772
+287 ;;^UTILITY(U,$J,358.3,34397,0)
+288 ;;=D57.01^^105^1433^85
+289 ;;^UTILITY(U,$J,358.3,34397,1,0)
+290 ;;=^358.31IA^4^2
+291 ;;^UTILITY(U,$J,358.3,34397,1,3,0)
+292 ;;=3^Hb-SS Disease w/ Acute Chest Syndrome
+293 ;;^UTILITY(U,$J,358.3,34397,1,4,0)
+294 ;;=4^D57.01
+295 ;;^UTILITY(U,$J,358.3,34397,2)
+296 ;;=^5002307
+297 ;;^UTILITY(U,$J,358.3,34398,0)
+298 ;;=D57.00^^105^1433^86
+299 ;;^UTILITY(U,$J,358.3,34398,1,0)
+300 ;;=^358.31IA^4^2
+301 ;;^UTILITY(U,$J,358.3,34398,1,3,0)
+302 ;;=3^Hb-SS Disease w/ Crisis,Unspec
+303 ;;^UTILITY(U,$J,358.3,34398,1,4,0)
+304 ;;=4^D57.00
+305 ;;^UTILITY(U,$J,358.3,34398,2)
+306 ;;=^5002306
+307 ;;^UTILITY(U,$J,358.3,34399,0)
+308 ;;=D57.02^^105^1433^87
+309 ;;^UTILITY(U,$J,358.3,34399,1,0)
+310 ;;=^358.31IA^4^2
+311 ;;^UTILITY(U,$J,358.3,34399,1,3,0)
+312 ;;=3^Hb-SS Disease w/ Splenic Sequestration
+313 ;;^UTILITY(U,$J,358.3,34399,1,4,0)
+314 ;;=4^D57.02
+315 ;;^UTILITY(U,$J,358.3,34399,2)
+316 ;;=^5002308
+317 ;;^UTILITY(U,$J,358.3,34400,0)
+318 ;;=D68.32^^105^1433^89
+319 ;;^UTILITY(U,$J,358.3,34400,1,0)
+320 ;;=^358.31IA^4^2
+321 ;;^UTILITY(U,$J,358.3,34400,1,3,0)
+322 ;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
+323 ;;^UTILITY(U,$J,358.3,34400,1,4,0)
+324 ;;=4^D68.32
+325 ;;^UTILITY(U,$J,358.3,34400,2)
+326 ;;=^5002357
+327 ;;^UTILITY(U,$J,358.3,34401,0)
+328 ;;=C22.2^^105^1433^90
+329 ;;^UTILITY(U,$J,358.3,34401,1,0)
+330 ;;=^358.31IA^4^2
+331 ;;^UTILITY(U,$J,358.3,34401,1,3,0)
+332 ;;=3^Hepatoblastoma
+333 ;;^UTILITY(U,$J,358.3,34401,1,4,0)
+334 ;;=4^C22.2
+335 ;;^UTILITY(U,$J,358.3,34401,2)
+336 ;;=^5000935
+337 ;;^UTILITY(U,$J,358.3,34402,0)
+338 ;;=D58.9^^105^1433^92
+339 ;;^UTILITY(U,$J,358.3,34402,1,0)
+340 ;;=^358.31IA^4^2
+341 ;;^UTILITY(U,$J,358.3,34402,1,3,0)
+342 ;;=3^Hereditary Hemolytic Anemia,Unspec
+343 ;;^UTILITY(U,$J,358.3,34402,1,4,0)
+344 ;;=4^D58.9
+345 ;;^UTILITY(U,$J,358.3,34402,2)
+346 ;;=^5002322
+347 ;;^UTILITY(U,$J,358.3,34403,0)
+348 ;;=C81.99^^105^1433^93
+349 ;;^UTILITY(U,$J,358.3,34403,1,0)
+350 ;;=^358.31IA^4^2
+351 ;;^UTILITY(U,$J,358.3,34403,1,3,0)
+352 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
+353 ;;^UTILITY(U,$J,358.3,34403,1,4,0)
+354 ;;=4^C81.99
+355 ;;^UTILITY(U,$J,358.3,34403,2)
+356 ;;=^5001460
+357 ;;^UTILITY(U,$J,358.3,34404,0)
+358 ;;=C81.90^^105^1433^94
+359 ;;^UTILITY(U,$J,358.3,34404,1,0)
+360 ;;=^358.31IA^4^2
+361 ;;^UTILITY(U,$J,358.3,34404,1,3,0)
+362 ;;=3^Hodgkin Lymphoma,Unspec Site
+363 ;;^UTILITY(U,$J,358.3,34404,1,4,0)
+364 ;;=4^C81.90
+365 ;;^UTILITY(U,$J,358.3,34404,2)
+366 ;;=^5001451
+367 ;;^UTILITY(U,$J,358.3,34405,0)
+368 ;;=D89.2^^105^1433^95
+369 ;;^UTILITY(U,$J,358.3,34405,1,0)
+370 ;;=^358.31IA^4^2
+371 ;;^UTILITY(U,$J,358.3,34405,1,3,0)
+372 ;;=3^Hypergammaglobulenemia,Unspec
+373 ;;^UTILITY(U,$J,358.3,34405,1,4,0)
+374 ;;=4^D89.2
+375 ;;^UTILITY(U,$J,358.3,34405,2)
+376 ;;=^5002455
+377 ;;^UTILITY(U,$J,358.3,34406,0)
+378 ;;=D05.12^^105^1433^98
+379 ;;^UTILITY(U,$J,358.3,34406,1,0)
+380 ;;=^358.31IA^4^2
+381 ;;^UTILITY(U,$J,358.3,34406,1,3,0)
+382 ;;=3^Intraductal Carcinoma in Situ,Left Breast
+383 ;;^UTILITY(U,$J,358.3,34406,1,4,0)
+384 ;;=4^D05.12
+385 ;;^UTILITY(U,$J,358.3,34406,2)
+386 ;;=^5001931
+387 ;;^UTILITY(U,$J,358.3,34407,0)
+388 ;;=D05.11^^105^1433^99
+389 ;;^UTILITY(U,$J,358.3,34407,1,0)
+390 ;;=^358.31IA^4^2
+391 ;;^UTILITY(U,$J,358.3,34407,1,3,0)
+392 ;;=3^Intraductal Carcinoma in Situ,Right Breast
+393 ;;^UTILITY(U,$J,358.3,34407,1,4,0)
+394 ;;=4^D05.11
+395 ;;^UTILITY(U,$J,358.3,34407,2)
+396 ;;=^5001930
+397 ;;^UTILITY(U,$J,358.3,34408,0)
+398 ;;=D05.10^^105^1433^100
+399 ;;^UTILITY(U,$J,358.3,34408,1,0)
+400 ;;=^358.31IA^4^2
+401 ;;^UTILITY(U,$J,358.3,34408,1,3,0)
+402 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
+403 ;;^UTILITY(U,$J,358.3,34408,1,4,0)
+404 ;;=4^D05.10
+405 ;;^UTILITY(U,$J,358.3,34408,2)
+406 ;;=^5001929
+407 ;;^UTILITY(U,$J,358.3,34409,0)
+408 ;;=D50.0^^105^1433^101
+409 ;;^UTILITY(U,$J,358.3,34409,1,0)
+410 ;;=^358.31IA^4^2
+411 ;;^UTILITY(U,$J,358.3,34409,1,3,0)
+412 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
+413 ;;^UTILITY(U,$J,358.3,34409,1,4,0)
+414 ;;=4^D50.0
+415 ;;^UTILITY(U,$J,358.3,34409,2)
+416 ;;=^267971
+417 ;;^UTILITY(U,$J,358.3,34410,0)
+418 ;;=D50.9^^105^1433^102
+419 ;;^UTILITY(U,$J,358.3,34410,1,0)
+420 ;;=^358.31IA^4^2
+421 ;;^UTILITY(U,$J,358.3,34410,1,3,0)
+422 ;;=3^Iron Deficiency Anemia,Unspec
+423 ;;^UTILITY(U,$J,358.3,34410,1,4,0)
+424 ;;=4^D50.9
+425 ;;^UTILITY(U,$J,358.3,34410,2)
+426 ;;=^5002283
+427 ;;^UTILITY(U,$J,358.3,34411,0)
+428 ;;=C46.9^^105^1433^103
+429 ;;^UTILITY(U,$J,358.3,34411,1,0)
+430 ;;=^358.31IA^4^2
+431 ;;^UTILITY(U,$J,358.3,34411,1,3,0)
+432 ;;=3^Kaposi's Sarcoma,Unspec
+433 ;;^UTILITY(U,$J,358.3,34411,1,4,0)
+434 ;;=4^C46.9
+435 ;;^UTILITY(U,$J,358.3,34411,2)
+436 ;;=^5001108
+437 ;;^UTILITY(U,$J,358.3,34412,0)
+438 ;;=C22.0^^105^1433^104
+439 ;;^UTILITY(U,$J,358.3,34412,1,0)
+440 ;;=^358.31IA^4^2
+441 ;;^UTILITY(U,$J,358.3,34412,1,3,0)
+442 ;;=3^Liver Cell Carcinoma
+443 ;;^UTILITY(U,$J,358.3,34412,1,4,0)
+444 ;;=4^C22.0
+445 ;;^UTILITY(U,$J,358.3,34412,2)
+446 ;;=^5000933
+447 ;;^UTILITY(U,$J,358.3,34413,0)
+448 ;;=D05.02^^105^1433^105
+449 ;;^UTILITY(U,$J,358.3,34413,1,0)
+450 ;;=^358.31IA^4^2
+451 ;;^UTILITY(U,$J,358.3,34413,1,3,0)
+452 ;;=3^Lobular Carcinoma in Situ,Left Breast
+453 ;;^UTILITY(U,$J,358.3,34413,1,4,0)
+454 ;;=4^D05.02
+455 ;;^UTILITY(U,$J,358.3,34413,2)
+456 ;;=^5001928
+457 ;;^UTILITY(U,$J,358.3,34414,0)
+458 ;;=D05.01^^105^1433^106
+459 ;;^UTILITY(U,$J,358.3,34414,1,0)
+460 ;;=^358.31IA^4^2
+461 ;;^UTILITY(U,$J,358.3,34414,1,3,0)
+462 ;;=3^Lobular Carcinoma in Situ,Right Breast
+463 ;;^UTILITY(U,$J,358.3,34414,1,4,0)
+464 ;;=4^D05.01
+465 ;;^UTILITY(U,$J,358.3,34414,2)
+466 ;;=^5001927
+467 ;;^UTILITY(U,$J,358.3,34415,0)
+468 ;;=D05.00^^105^1433^107
+469 ;;^UTILITY(U,$J,358.3,34415,1,0)
+470 ;;=^358.31IA^4^2
+471 ;;^UTILITY(U,$J,358.3,34415,1,3,0)
+472 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
+473 ;;^UTILITY(U,$J,358.3,34415,1,4,0)
+474 ;;=4^D05.00
+475 ;;^UTILITY(U,$J,358.3,34415,2)
+476 ;;=^5001926
+477 ;;^UTILITY(U,$J,358.3,34416,0)
+478 ;;=R59.0^^105^1433^66
+479 ;;^UTILITY(U,$J,358.3,34416,1,0)
+480 ;;=^358.31IA^4^2
+481 ;;^UTILITY(U,$J,358.3,34416,1,3,0)
+482 ;;=3^Enlarged Lymph Nodes,Localized
+483 ;;^UTILITY(U,$J,358.3,34416,1,4,0)
+484 ;;=4^R59.0
+485 ;;^UTILITY(U,$J,358.3,34416,2)
+486 ;;=^5019529
+487 ;;^UTILITY(U,$J,358.3,34417,0)
+488 ;;=C83.59^^105^1433^108
+489 ;;^UTILITY(U,$J,358.3,34417,1,0)
+490 ;;=^358.31IA^4^2
+491 ;;^UTILITY(U,$J,358.3,34417,1,3,0)
+492 ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
+493 ;;^UTILITY(U,$J,358.3,34417,1,4,0)
+494 ;;=4^C83.59
+495 ;;^UTILITY(U,$J,358.3,34417,2)
+496 ;;=^5001590
+497 ;;^UTILITY(U,$J,358.3,34418,0)
+498 ;;=C83.50^^105^1433^109
+499 ;;^UTILITY(U,$J,358.3,34418,1,0)
+500 ;;=^358.31IA^4^2
+501 ;;^UTILITY(U,$J,358.3,34418,1,3,0)
+502 ;;=3^Lymphoblastic Lymphoma,Unspec Site
+503 ;;^UTILITY(U,$J,358.3,34418,1,4,0)
+504 ;;=4^C83.50
+505 ;;^UTILITY(U,$J,358.3,34418,2)
+506 ;;=^5001581
+507 ;;^UTILITY(U,$J,358.3,34419,0)
+508 ;;=C43.9^^105^1433^112
+509 ;;^UTILITY(U,$J,358.3,34419,1,0)
+510 ;;=^358.31IA^4^2
+511 ;;^UTILITY(U,$J,358.3,34419,1,3,0)
+512 ;;=3^Malig Melanoma of Skin,Unspec Site
+513 ;;^UTILITY(U,$J,358.3,34419,1,4,0)
+514 ;;=4^C43.9
+515 ;;^UTILITY(U,$J,358.3,34419,2)
+516 ;;=^5001015
+517 ;;^UTILITY(U,$J,358.3,34420,0)
+518 ;;=C31.9^^105^1433^113
+519 ;;^UTILITY(U,$J,358.3,34420,1,0)
+520 ;;=^358.31IA^4^2
+521 ;;^UTILITY(U,$J,358.3,34420,1,3,0)
+522 ;;=3^Malig Neop Accessory Sinus,Unspec
+523 ;;^UTILITY(U,$J,358.3,34420,1,4,0)
+524 ;;=4^C31.9
+525 ;;^UTILITY(U,$J,358.3,34420,2)
+526 ;;=^5000953
+527 ;;^UTILITY(U,$J,358.3,34421,0)
+528 ;;=C24.1^^105^1433^115
+529 ;;^UTILITY(U,$J,358.3,34421,1,0)
+530 ;;=^358.31IA^4^2
+531 ;;^UTILITY(U,$J,358.3,34421,1,3,0)
+532 ;;=3^Malig Neop Ampulla of Vater
+533 ;;^UTILITY(U,$J,358.3,34421,1,4,0)
+534 ;;=4^C24.1
+535 ;;^UTILITY(U,$J,358.3,34421,2)
+536 ;;=^267100
+537 ;;^UTILITY(U,$J,358.3,34422,0)
+538 ;;=C21.0^^105^1433^116
+539 ;;^UTILITY(U,$J,358.3,34422,1,0)
+540 ;;=^358.31IA^4^2
+541 ;;^UTILITY(U,$J,358.3,34422,1,3,0)
+542 ;;=3^Malig Neop Anus,Unspec
+543 ;;^UTILITY(U,$J,358.3,34422,1,4,0)
+544 ;;=4^C21.0
+545 ;;^UTILITY(U,$J,358.3,34422,2)
+546 ;;=^5000930
+547 ;;^UTILITY(U,$J,358.3,34423,0)
+548 ;;=C67.9^^105^1433^119
+549 ;;^UTILITY(U,$J,358.3,34423,1,0)
+550 ;;=^358.31IA^4^2
+551 ;;^UTILITY(U,$J,358.3,34423,1,3,0)
+552 ;;=3^Malig Neop Bladder,Unspec
+553 ;;^UTILITY(U,$J,358.3,34423,1,4,0)
+554 ;;=4^C67.9
+555 ;;^UTILITY(U,$J,358.3,34423,2)
+556 ;;=^5001263
+557 ;;^UTILITY(U,$J,358.3,34424,0)
+558 ;;=C71.9^^105^1433^123
+559 ;;^UTILITY(U,$J,358.3,34424,1,0)
+560 ;;=^358.31IA^4^2
+561 ;;^UTILITY(U,$J,358.3,34424,1,3,0)
+562 ;;=3^Malig Neop Brain,Unspec
+563 ;;^UTILITY(U,$J,358.3,34424,1,4,0)
+564 ;;=4^C71.9
+565 ;;^UTILITY(U,$J,358.3,34424,2)
+566 ;;=^5001297
+567 ;;^UTILITY(U,$J,358.3,34425,0)
+568 ;;=C18.9^^105^1433^125
+569 ;;^UTILITY(U,$J,358.3,34425,1,0)
+570 ;;=^358.31IA^4^2
+571 ;;^UTILITY(U,$J,358.3,34425,1,3,0)
+572 ;;=3^Malig Neop Colon,Unspec
+573 ;;^UTILITY(U,$J,358.3,34425,1,4,0)
+574 ;;=4^C18.9
+575 ;;^UTILITY(U,$J,358.3,34425,2)
+576 ;;=^5000929
+577 ;;^UTILITY(U,$J,358.3,34426,0)
+578 ;;=C49.9^^105^1433^126
+579 ;;^UTILITY(U,$J,358.3,34426,1,0)
+580 ;;=^358.31IA^4^2
+581 ;;^UTILITY(U,$J,358.3,34426,1,3,0)
+582 ;;=3^Malig Neop Connective/Soft Tissue,Unspec
+583 ;;^UTILITY(U,$J,358.3,34426,1,4,0)
+584 ;;=4^C49.9
+585 ;;^UTILITY(U,$J,358.3,34426,2)
+586 ;;=^5001136
+587 ;;^UTILITY(U,$J,358.3,34427,0)
+588 ;;=C62.12^^105^1433^127
+589 ;;^UTILITY(U,$J,358.3,34427,1,0)
+590 ;;=^358.31IA^4^2
+591 ;;^UTILITY(U,$J,358.3,34427,1,3,0)
+592 ;;=3^Malig Neop Descended Left Testis
+593 ;;^UTILITY(U,$J,358.3,34427,1,4,0)
+594 ;;=4^C62.12
+595 ;;^UTILITY(U,$J,358.3,34427,2)
+596 ;;=^5001235
+597 ;;^UTILITY(U,$J,358.3,34428,0)
+598 ;;=C62.11^^105^1433^128
+599 ;;^UTILITY(U,$J,358.3,34428,1,0)
+600 ;;=^358.31IA^4^2
+601 ;;^UTILITY(U,$J,358.3,34428,1,3,0)
+602 ;;=3^Malig Neop Descended Right Testis
+603 ;;^UTILITY(U,$J,358.3,34428,1,4,0)
+604 ;;=4^C62.11
+605 ;;^UTILITY(U,$J,358.3,34428,2)
+606 ;;=^5001234
+607 ;;^UTILITY(U,$J,358.3,34429,0)
+608 ;;=C15.9^^105^1433^129
+609 ;;^UTILITY(U,$J,358.3,34429,1,0)
+610 ;;=^358.31IA^4^2
+611 ;;^UTILITY(U,$J,358.3,34429,1,3,0)
+612 ;;=3^Malig Neop Esophagus,Unspec
+613 ;;^UTILITY(U,$J,358.3,34429,1,4,0)
+614 ;;=4^C15.9
+615 ;;^UTILITY(U,$J,358.3,34429,2)
+616 ;;=^5000919
+617 ;;^UTILITY(U,$J,358.3,34430,0)
+618 ;;=C24.0^^105^1433^130
+619 ;;^UTILITY(U,$J,358.3,34430,1,0)
+620 ;;=^358.31IA^4^2
+621 ;;^UTILITY(U,$J,358.3,34430,1,3,0)
+622 ;;=3^Malig Neop Extrahepatic Bile Duct
+623 ;;^UTILITY(U,$J,358.3,34430,1,4,0)
+624 ;;=4^C24.0
+625 ;;^UTILITY(U,$J,358.3,34430,2)
+626 ;;=^5000940
+627 ;;^UTILITY(U,$J,358.3,34431,0)
+628 ;;=C23.^^105^1433^132
+629 ;;^UTILITY(U,$J,358.3,34431,1,0)
+630 ;;=^358.31IA^4^2
+631 ;;^UTILITY(U,$J,358.3,34431,1,3,0)
+632 ;;=3^Malig Neop Gallbladder
+633 ;;^UTILITY(U,$J,358.3,34431,1,4,0)
+634 ;;=4^C23.
+635 ;;^UTILITY(U,$J,358.3,34431,2)
+636 ;;=^267098
+637 ;;^UTILITY(U,$J,358.3,34432,0)
+638 ;;=C32.9^^105^1433^136
+639 ;;^UTILITY(U,$J,358.3,34432,1,0)
+640 ;;=^358.31IA^4^2
+641 ;;^UTILITY(U,$J,358.3,34432,1,3,0)
+642 ;;=3^Malig Neop Larynx,Unspec
+643 ;;^UTILITY(U,$J,358.3,34432,1,4,0)
+644 ;;=4^C32.9
+645 ;;^UTILITY(U,$J,358.3,34432,2)
+646 ;;=^5000956
+647 ;;^UTILITY(U,$J,358.3,34433,0)
+648 ;;=C64.2^^105^1433^140
+649 ;;^UTILITY(U,$J,358.3,34433,1,0)
+650 ;;=^358.31IA^4^2
+651 ;;^UTILITY(U,$J,358.3,34433,1,3,0)
+652 ;;=3^Malig Neop Left Kidney,Except Renal Pelvis
+653 ;;^UTILITY(U,$J,358.3,34433,1,4,0)
+654 ;;=4^C64.2
+655 ;;^UTILITY(U,$J,358.3,34433,2)
+656 ;;=^5001249
+657 ;;^UTILITY(U,$J,358.3,34434,0)
+658 ;;=C65.2^^105^1433^143
+659 ;;^UTILITY(U,$J,358.3,34434,1,0)
+660 ;;=^358.31IA^4^2
+661 ;;^UTILITY(U,$J,358.3,34434,1,3,0)
+662 ;;=3^Malig Neop Left Renal Pelvis
+663 ;;^UTILITY(U,$J,358.3,34434,1,4,0)
+664 ;;=4^C65.2
+665 ;;^UTILITY(U,$J,358.3,34434,2)
+666 ;;=^5001252
+667 ;;^UTILITY(U,$J,358.3,34435,0)
+668 ;;=C62.92^^105^1433^144
